Neurocrine Biosciences, Inc.

NB3.F·Frankfurt·Healthcare
Compare
125.70+5.20 (+4.32%)today
As of Oct 21, 8:03 AM CEST · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close120.50
Open125.70
Day range—
52-week range102.55160.50
Off day high0.00%
Off 52-week high−21.68%
Volume707
Avg. volume (3M)42.00
Market cap12.78B
EPS (TTM)5.85
Forward P/E32.56
P/E ratio (TTM)21.49
Dividend yield—
Beta (5Y)0.40
Shares outstanding101.65M
Short interest—
Earnings dateNov 2, 2026
Analyst target—
Profit margin20.91%

Against its peers

Compare in full ›
NB3.F ALKS SUPN AMLX 42C.SI BCRX
Market cap 12.78B 7.30B 2.40B 3.64B 558.96M 1.98B
P/E (TTM) 21.5 114.6 — — — —
Forward P/E 32.6 24.1 9.6 -26.6 268.4 7.8
Price/book 3.9 4.0 2.3 13.5 36.4 -4.4
Dividend yield — — — — — —
1-year change −1.23% +41.88% −18.63% +94.13% +523.46% +12.15%
Today +4.32% −1.29% −0.05% +0.90% +0.99% −2.39%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.

Related companies

Compare ›

Also based in San Diego, California, then elsewhere in California.

Company Mkt cap Price Today
QUALCOMM IncorporatedQCOM · San Diego, CAOdds 190.03B 177.96 +1.28%
Illumina, Inc.ILMN · San Diego, CA 42.71B 282.86 +5.57%
Realty Income CorporationO · San Diego, CA 52.37B 55.35 −1.76%
SempraSRE · San Diego, CA 54.60B 83.50 +0.83%
ResMed Inc.RMD · San Diego, CA 34.63B 246.20 +0.29%
DexCom, Inc.DXCM · San Diego, CA 30.29B 80.26 −6.39%
LPL Financial Holdings Inc.LPLA · San Diego, CAOdds 25.28B 321.03 −0.26%
Halozyme Therapeutics, Inc.HALO · San Diego, CA 14.17B 124.83 +0.37%

What visitors to Neurocrine Biosciences's page also look at.

Company Mkt cap Price Today
VERTEX PHARMACEUTICALS INC.VX1.F 115.67B 456.35 +2.52%
Incyte Corp.ICY.F 20.99B 103.55 +2.12%
Halozyme Therapeutics Inc.RV7.F 12.63B 111.30 +0.77%
Sarepta Therapeutics Inc.AB3A.F 1.80B 17.02 +9.81%
Alnylam Pharmaceuticals IncDUL.F 27.00B 201.80 −1.18%

From the 4Search instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All NB3.F news ›
Stock Titan·

Neurocrine Biosciences: JPMorgan reports 5.2% stake

JPMorgan reports a passive stake in Neurocrine Biosciences (NBIX) Stock Titan - [SCHEDULE 13G/A] NEUROCRINE BIOSCIENCES INC Amended Passive Investment Disclosure Neurocrine Biosciences: JPMorgan reports 5.2% stake Neurocrine Biosciences,…

From articles in the 4Search news index.

In the news

11mentions in 30 days
11with it in the headline
Positivesentiment

Mentioned with

Neurocrine Biosciences, Inc.5Eli Lilly4Cns Pharmaceuticals3Cns Pharmaceuticals, Inc3Connect Biopharma3Neurogene Inc3Nvidia3Astrazeneca2

People in the coverage

Mitch Edgeman9Danessa Lincoln5Kim Johansen5Marketbeat4Neurogene4Balyasny3

Themes

Healthcare7Earnings5Beneficial Ownership3Biotechnology3Comparison3EPS3Form 43Institutional Ownership3

Most coverage from

  1. stocktitan.net3
  2. themarketsdaily.com2
  3. contractpharma.com1
  4. defenseworld.net1
  5. insidermonkey.com1

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 11 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.